Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ott

Showing results (481-490 of 504) with videos related to

Pageof 51
Sort By:
Sleep|August 21, 2025
Towards Long-Term Sleep Staging via Wearable Reflective PhotoplethysmographyLoris Constantin, Christian M Horvath, Florent Baty, et al.
Journal of Medicinal Chemistry|May 9, 2012
Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinaseDiane E Gingrich, Joseph G Lisko, Matthew A Curry, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic functionTyler F Hill, Anna E Helmers, Rene Yu-Hong Cheng, et al.
Molecular Therapy. Advances|May 15, 2026
Humanized mice enable <i>in vivo</i> evaluation of engineered plasma cell biology and therapeutic functionTyler F Hill, Anna E Helmers, Rene Yu-Hong Cheng, et al.
Journal of Medicinal Chemistry|August 24, 2011
2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activityGregory R Ott, Gregory J Wells, Tho V Thieu, et al.
Alzheimer Disease and Associated Disorders|April 30, 2016
Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal IndividualsCatherine M Roe, Peggy P Barco, Denise M Head, et al.
Lancet (London, England)|September 2, 2017
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trialRobert P Giugliano, Terje R Pedersen, Jeong-Gun Park, et al.
Regulatory Toxicology and Pharmacology : RTP|February 1, 2026
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity DataRobert Jolly, Alejandra Trejo-Martin, Joel P Bercu, et al.
Trials|January 23, 2021
Effect of early sleep apnoea treatment with adaptive servo-ventilation in acute stroke patients on cerebral lesion evolution and neurological outcomes: study protocol for a multicentre, randomized controlled, rater-blinded, clinical trial (eSATIS: early Sleep Apnoea Treatment in Stroke)Simone B Duss, Anne-Kathrin Brill, Sébastien Baillieul, et al.
Developmental Cognitive Neuroscience|August 11, 2023
Developmental alterations in the neural oscillatory dynamics underlying attentional reorientingGiorgia Picci, Lauren R Ott, Nathan M Petro, et al.
Pageof 51

Showing results (481-490 of 504) with videos related to

Sort By:
Pageof 51
Sleep|August 21, 2025
Towards Long-Term Sleep Staging via Wearable Reflective PhotoplethysmographyLoris Constantin, Christian M Horvath, Florent Baty, et al.
Journal of Medicinal Chemistry|May 9, 2012
Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinaseDiane E Gingrich, Joseph G Lisko, Matthew A Curry, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic functionTyler F Hill, Anna E Helmers, Rene Yu-Hong Cheng, et al.
Molecular Therapy. Advances|May 15, 2026
Humanized mice enable <i>in vivo</i> evaluation of engineered plasma cell biology and therapeutic functionTyler F Hill, Anna E Helmers, Rene Yu-Hong Cheng, et al.
Journal of Medicinal Chemistry|August 24, 2011
2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activityGregory R Ott, Gregory J Wells, Tho V Thieu, et al.
Alzheimer Disease and Associated Disorders|April 30, 2016
Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal IndividualsCatherine M Roe, Peggy P Barco, Denise M Head, et al.
Lancet (London, England)|September 2, 2017
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trialRobert P Giugliano, Terje R Pedersen, Jeong-Gun Park, et al.
Regulatory Toxicology and Pharmacology : RTP|February 1, 2026
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity DataRobert Jolly, Alejandra Trejo-Martin, Joel P Bercu, et al.
Trials|January 23, 2021
Effect of early sleep apnoea treatment with adaptive servo-ventilation in acute stroke patients on cerebral lesion evolution and neurological outcomes: study protocol for a multicentre, randomized controlled, rater-blinded, clinical trial (eSATIS: early Sleep Apnoea Treatment in Stroke)Simone B Duss, Anne-Kathrin Brill, Sébastien Baillieul, et al.
Developmental Cognitive Neuroscience|August 11, 2023
Developmental alterations in the neural oscillatory dynamics underlying attentional reorientingGiorgia Picci, Lauren R Ott, Nathan M Petro, et al.
Pageof 51